Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis.

Benjamin CastagnéMarie VipreyJulie MartinAnne-Marie SchottMichel CucheratMartin Soubrier

Published in: PloS one (2019)

Despite an increase in cholesterol levels, TCZ has safe cardiovascular outcomes compared to other bDMARD.

Keyphrases